CA Patent

CA2633380A1 — Nanoclusters for delivery of therapeutics

Assigned to University of Kansas · Expires 2007-07-05 · 19y expired

What this patent protects

The present invention discloses a nano-cluster that includes a plurality of nano-particles, wherein the nano-particles can disperse in response to an environmental cue. Also disclosed is a method of preventing, treating, or diagnosing a disease or condition in a subject comprisin…

USPTO Abstract

The present invention discloses a nano-cluster that includes a plurality of nano-particles, wherein the nano-particles can disperse in response to an environmental cue. Also disclosed is a method of preventing, treating, or diagnosing a disease or condition in a subject comprising administering a therapeutically effective amount of a composition comprising nano-clusters of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
CA2633380A1
Jurisdiction
CA
Classification
Expires
2007-07-05
Drug substance claim
No
Drug product claim
No
Assignee
University of Kansas
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.